TY - JOUR
T1 - Using voluntary cough to detect penetration and aspiration during oropharyngeal swallowing in patients with Parkinson disease
AU - Pitts, Teresa
AU - Troche, Michelle
AU - Mann, Giselle
AU - Rosenbek, John
AU - Okun, Michael S.
AU - Sapienza, Christine
N1 - Funding Information:
Financial/nonfinancial disclosures: The authors have reported to CHEST the following conflicts of interest: Dr Okun has received grant support from the US National Institutes of Health, National Parkinson Foundation, Michael J. Fox Foundation, and the Parkinson Alliance. He has a potential royalty interest in a scale developed for COMPRESS. He has received book royalties from Demos, Manson, and Humana. He has received Medtronic training fellowships for educational training at the University of Florida (peer reviewed). Prior to 2010, he has received honoraria for teaching deep brain stimulation and deep brain stimulation programming at courses sponsored by Medtronic. He has taught in University of South Florida, American Academy of Neurology, and Movement Disorders Society continuing medical education programs. Dr Sapienza has received funding for support of this project through the US National Institutes of Health and the Michael J. Fox Foundation for Parkinson's Research. She serves on the scientific advisory board of Aspire Products, LLC, and receives renumeration for her service. Dr Sapienza also has spoken on the application of respiratory muscle strength training four to six times per year for the last 3 years. Drs Pitts, Troche, Mann, and Rosenbek have reported no conflicts.
PY - 2010/12/1
Y1 - 2010/12/1
N2 - Background: Identification of people with Parkinson disease (PD) who are at risk for aspiration is important, especially because of the high prevalence of aspiration pneumonia. Methods: Fifty-eight consecutive patients (Hoehn and Yahr stage II-III; average age 72.3) were enrolled in the study. Measures of airflow during voluntary cough production and the degree of penetration/aspiration on a 3-oz oropharyngeal swallow task, derived from videofluorographic images, were examined. Results: To detect at-risk people (those with penetration and/or aspiration on the 3-oz swallow task), four objective measures of voluntary cough (compression phase duration [CPD], expiratory phase rise time [EPRT], expiratory phase peak flow [EPPF], and cough volume acceleration [CVA)]) were collected. CPD, EPRT, EPPF, and CVA measurements produced significant area under the curve (AUC) analyses and likelihood ratios equal to 0.83:2.72, 0.71:2.68, 0.69:1.75, and 0.78:18.42, respectively. CPD, EPRT, EPPF, and CVA measurements demonstrated sensitivities of 95.83%, 70.83%, 87.50%, and 84.53%, and specificities of 64.71%, 73.53%, 50.01%, and 97.06%, respectively. For detection of aspiration, EPPF was significantly associated with an AUC = 0.88 and with an EPPF, 5.24, which had a sensitivity of 57.15% and a specificity of 100%. Conclusions: The data from this pilot study suggest that in patients with PD, objective airflow measures from voluntary cough production may identify at-risk penetrator/aspirators. To our knowledge, this is the first study to evaluate the discriminative ability of voluntary cough airflow characteristics to model airway compromise in people with PD.
AB - Background: Identification of people with Parkinson disease (PD) who are at risk for aspiration is important, especially because of the high prevalence of aspiration pneumonia. Methods: Fifty-eight consecutive patients (Hoehn and Yahr stage II-III; average age 72.3) were enrolled in the study. Measures of airflow during voluntary cough production and the degree of penetration/aspiration on a 3-oz oropharyngeal swallow task, derived from videofluorographic images, were examined. Results: To detect at-risk people (those with penetration and/or aspiration on the 3-oz swallow task), four objective measures of voluntary cough (compression phase duration [CPD], expiratory phase rise time [EPRT], expiratory phase peak flow [EPPF], and cough volume acceleration [CVA)]) were collected. CPD, EPRT, EPPF, and CVA measurements produced significant area under the curve (AUC) analyses and likelihood ratios equal to 0.83:2.72, 0.71:2.68, 0.69:1.75, and 0.78:18.42, respectively. CPD, EPRT, EPPF, and CVA measurements demonstrated sensitivities of 95.83%, 70.83%, 87.50%, and 84.53%, and specificities of 64.71%, 73.53%, 50.01%, and 97.06%, respectively. For detection of aspiration, EPPF was significantly associated with an AUC = 0.88 and with an EPPF, 5.24, which had a sensitivity of 57.15% and a specificity of 100%. Conclusions: The data from this pilot study suggest that in patients with PD, objective airflow measures from voluntary cough production may identify at-risk penetrator/aspirators. To our knowledge, this is the first study to evaluate the discriminative ability of voluntary cough airflow characteristics to model airway compromise in people with PD.
UR - https://www.scopus.com/pages/publications/78649844795
UR - https://www.scopus.com/pages/publications/78649844795#tab=citedBy
U2 - 10.1378/chest.10-0342
DO - 10.1378/chest.10-0342
M3 - Article
C2 - 20705802
AN - SCOPUS:78649844795
SN - 0012-3692
VL - 138
SP - 1426
EP - 1431
JO - Chest
JF - Chest
IS - 6
ER -